Endodiag
2 known investors
Find your way into Endodiag
Sign up to see every warm intro you have to Endodiag
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Endodiag team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Endodiag develops non-invasive diagnostic tests based on blood biomarkers to identify endometriosis in women, addressing a condition currently requiring surgical diagnosis. The company also creates solutions to map patient disease for personalized treatment and fertility management.
Investors · 2
Karistalisted by KaristaParis · $324K – $5.4M
How we know: Karista's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Endodiag do?
- Endodiag develops non-invasive diagnostic tests based on blood biomarkers to identify endometriosis in women, addressing a condition currently requiring surgical diagnosis. The company also creates solutions to map patient disease for personalized treatment and fertility management.
- Who are Endodiag's investors?
- Endodiag's investors include CapDecisif Management, Karista.
